159
Views
2
CrossRef citations to date
0
Altmetric
Commentaries

Improving end-of-life care for patients with leukemia: is inpatient death the right measure?

ORCID Icon
Pages 2546-2548 | Received 09 Oct 2020, Accepted 13 Oct 2020, Published online: 29 Oct 2020

References

  • Mohyuddin GA, Abbasi S, Ripp J, et al. Patients with leukemia dying in the hospital: results of the national inpatient sample and a call to do better. Leuk Lymphoma. 2020;61(1):2760–2762.
  • LeBlanc TW, El-Jawahri A. When and why should patients with hematologic malignancies see a palliative care specialist? Hematol Am Soc Hematol Educ Program. 2015;2015:471–478.
  • LeBlanc TW, El-Jawahri A. Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care? Curr Opin Support Palliat Care. 2018;12(4):530–537.
  • LeBlanc TW, Roeland EJ, El-Jawahri A. Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep. 2017;12(4):300–308.
  • LeBlanc TW, Abernethy AP, Casarett DJ. What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage. 2015;49(3):505–512.
  • LeBlanc TW. Addressing end-of-life quality gaps in hematologic cancers: the importance of early concurrent palliative care. JAMA Intern Med. 2016;176(2):265–266.
  • LeBlanc TW. Palliative care and hematologic malignancies: old dog, new tricks? J Oncol Pract. 2014;10(6):e404–e407.
  • McCaughan D, Roman E, Smith AG, et al. Determinants of hospital death in haematological cancers: findings from a qualitative study. BMJ Support Palliat Care. 2018;8(1):78–86.
  • Howell DA, Wang HI, Roman E, et al. Preferred and actual place of death in haematological malignancy. BMJ Support Palliat Care. 2017;7(2):150–157.
  • Lowe JR, Yu Y, Wolf S, et al. A cohort study of patient-reported outcomes and healthcare utilization in acute myeloid leukemia patients receiving active cancer therapy in the last six months of life. J Palliat Med. 2018;21(5):592–597.
  • To THM, LeBlanc TW, Eastman P, et al. The prospective evaluation of the net effect of red blood cell transfusions in routine provision of palliative care. J Palliat Med. 2017;20(10):1152–1157.
  • LeBlanc TW, Egan PC, Olszewski AJ. Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood. 2018;132(7):717–726.
  • Odejide OO, Steensma DP. Patients with haematological malignancies should not have to choose between transfusions and hospice care. Lancet Haematol. 2020;7(5):e418–e424.
  • Rao VB, Belanger E, Egan PC, et al. Early palliative care services and end-of-life care in medicare beneficiaries with hematologic malignancies: a population-based retrospective cohort study. J Palliat Med. 2020. DOI: 10.1089/jpm.2020.0006
  • El-Jawahri A, Traeger L, Greer JA, et al. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol. 2017;35(32):3714–3721.
  • El-Jawahri A, LeBlanc T, VanDusen H, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2016;316(20):2094–2103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.